The Big 7: Companies Driving the Trispecific Antibody Revolution

added article Văn học

2025-07-25 09:20:49 -

In the ever-evolving field of immunotherapy, trispecific antibodies are quickly gaining momentum as the next-generation approach in targeted cancer treatment. These innovative biologics can bind to three different targets at once, boosting therapeutic precision and immune engagement. This unique mechanism is proving especially valuable in solid tumors and hematologic malignancies. Sanofi has...

0 Comments 0 Shares 79 Views